Page last updated: 2024-12-10

petromyzonol sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

petromyzonol sulfate: bile alocohol derivative that serves as a chemoattractant during the life cycle of sea lamprey (Petromyzon marinus) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5200193
CHEBI ID50109
SCHEMBL ID13760030
MeSH IDM0484547

Synonyms (17)

Synonym
3alpha,7alpha,12alpha-trihydroxy-5alpha-cholan-24-yl hydrogen sulfate
3alpha,7alpha,12alpha-trihydroxy-5alpha-cholan-24-yl sulfate
CHEBI:50109
5alpha-cholan-3alpha,7alpha,12alpha-triol 24-sulfate
petromyzonol 24-sulfate
LMST05020018
[(4r)-4-[(3r,5r,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentyl] hydrogen sulfate
petromyzonol sulfate
20311-93-7
3n46rr2q4e ,
cholane-3,7,12,24-tetrol, 24-(hydrogen sulfate), (3alpha,5alpha,7alpha,12alpha)-
5beta-petromyzonol sulfate
unii-3n46rr2q4e
SCHEMBL13760030
cholane-3,7,12,24-tetrol, 24-(hydrogen sulfate), (3.alpha.,5.alpha.,7.alpha.,12.alpha.)-
DTXSID70897722
Q27121911
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
steroid sulfateA sulfuric ester obtained by the formal condensation of a hydroxy group of any steroid with sulfuric acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (26.32)29.6817
2010's12 (63.16)24.3611
2020's2 (10.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.77

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.77 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.77)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]